(Total Views: 183)
Posted On: 02/26/2019 8:51:26 AM
Post# of 36566
Reminder: Investor Conference Call Today, February 26, 2019; Management to Provide Update on Initiatives & Strategic Plans, Call-in Details
8:00 AM ET, 02/26/2019 - GlobeNewswire
MIRAMAR, FL, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team today February 26, at 11:00 AM Eastern time:
Investors & persons of interest calling into event:
Domestic US/Canada - 1-888-632-3385
Direct Toll / International - 1-785-424-1673
Conference ID - 85014
The purpose of the call is to update investors on the previously announced and pending acquisitions that offer significant value to the Generex parent company. Joseph Moscato, Generex President & Chief Executive Officer, will discuss the company’s financing plans related to the acquisitions, as well as the strategic focus of Generex for 2019 and beyond. Topics for discussion include:
Potential Acquisition of 13 Hospitals as well as Hospital IT and Management companyPotential Acquisition of World Class Nutraceutical CompanyPotential Acquisition of Home Delivered Medically Approved Foods Business for Chronic Care of diabetes, cancer, cardiovascular, and rheumatoid arthritis patientsAcquisition of Direct to Patient End to End Pharmacy BusinessUpdate on Fuse Medical AcquisitionUpdate on Medisource Partners AcquisitionUpdate on Pantheon AcquisitionUpdate on NuGenerex Immuno-Oncology (NGIO) dividend and Go Public StrategyAcquisition plans for NGIO Merger with Company with Synergistic PlatformsNGIO Acquisition of World Class IPDiscussion of financial and legal issue
8:00 AM ET, 02/26/2019 - GlobeNewswire
MIRAMAR, FL, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team today February 26, at 11:00 AM Eastern time:
Investors & persons of interest calling into event:
Domestic US/Canada - 1-888-632-3385
Direct Toll / International - 1-785-424-1673
Conference ID - 85014
The purpose of the call is to update investors on the previously announced and pending acquisitions that offer significant value to the Generex parent company. Joseph Moscato, Generex President & Chief Executive Officer, will discuss the company’s financing plans related to the acquisitions, as well as the strategic focus of Generex for 2019 and beyond. Topics for discussion include:
Potential Acquisition of 13 Hospitals as well as Hospital IT and Management companyPotential Acquisition of World Class Nutraceutical CompanyPotential Acquisition of Home Delivered Medically Approved Foods Business for Chronic Care of diabetes, cancer, cardiovascular, and rheumatoid arthritis patientsAcquisition of Direct to Patient End to End Pharmacy BusinessUpdate on Fuse Medical AcquisitionUpdate on Medisource Partners AcquisitionUpdate on Pantheon AcquisitionUpdate on NuGenerex Immuno-Oncology (NGIO) dividend and Go Public StrategyAcquisition plans for NGIO Merger with Company with Synergistic PlatformsNGIO Acquisition of World Class IPDiscussion of financial and legal issue
(0)
(0)
